Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,121,633
+$232,125 QoQ
Shares Held
6,655
-1.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#385
of 768 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIL Ltd holds $565,763,475 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,381,783 | $386,734,925 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,752,506 | $127,134,902 | |
| 3 | VTRS |
Viatris Inc
|
2,118,598 | $33,643,336 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
114,279 | $12,678,112 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
92,207 | $2,269,214 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
3,947 | $2,138,603 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
6,655 | $1,121,633 | |
| 8 | HLN |
Haleon plc
|
4,582 | $42,750 |
All Filings in NBIX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,121,633 | 6,655 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $889,508 | 6,752 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $204,112 | 1,454 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $505,022 | 4,018 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $456,667 | 4,129 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,967,920 | 14,417 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,378,605 | 11,965 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,018,516 | 14,662 | Shares | Defined | 2024-08-13 | |
| 2020-12-31 | $12,939 | 135 | Shares | Defined | 2021-03-23 | |
| No filing history on record for this holder in this stock. | ||||||